BioLargo, Inc. will host an investor webcast and conference call on Wednesday August 17, 2021, at 8:00 am PST / 11:00 am EST, open to the public, to review the company’s financial results, discuss recent events, and conduct a question-and-answer session.
WESTMINSTER, CA / ACCESSWIRE / August 10, 2021 / BioLargo, Inc., (OTCQB:BLGO), a developer of sustainable technologies and full-service environmental engineering company, will host an investor webcast and conference call on Wednesday August 17, 2021, at 8:00 am PST / 11:00 am EST, open to the public, to review the company’s financial results, discuss recent events, and conduct a question-and-answer session.
The webcast, accompanying presentation materials, and teleconference replay will be made available on the Investor Relations section of BioLargo’s website for a limited period of time, at biolargo.com/investor-relations. To listen to the live broadcast, go to the site at least 15 minutes prior to the scheduled start time to register, download, and install any necessary audio/video software.
To participate in the live webcast and teleconference:
| Webcast Link: | |
| Teleconference Domestic: | 844-602-0380 |
| Teleconference International: | 862-298-0970 |
To watch or listen to a replay of the webcast or teleconference:
| Webcast Replay Expiration: | Wednesday, August 17, 2022 |
| Teleconference Replay Expiration: | Tuesday, August 31, 2021 |
| Teleconference Replay Domestic: | 877-481-4010 |
| Teleconference Replay International: | 919-882-2331 |
| Replay Passcode: | 42482 |
About BioLargo, Inc.
BioLargo, Inc. (OTCQB:BLGO) invents, develops, and commercializes innovative platform technologies to solve challenging environmental problems like PFAS contamination, advanced water and wastewater treatment, industrial odor and VOC control, air quality control, and infection control. With over 13 years of extensive R&D, BioLargo holds a wide array of issued patents, maintains a robust pipeline of products, and provides full-service environmental engineering. Our peer-reviewed scientific approach allows us to invent or acquire novel technologies and develop them to maturity through our operating subsidiaries. With a keen emphasis on collaborations with academic, municipal, and commercial organizations and associations, BioLargo has proven itself with over 80 awarded grants and numerous pilot projects. We monetize through direct sales, recurring service contracts, licensing agreements, strategic joint venture formation and/or the sale of the IP. Several of our technologies are commercially available and are advancing as disrupters in their respective markets. See our website at www.BioLargo.com.
Contact Information
Dennis P. Calvert
President and CEO, BioLargo, Inc.
888-400-2863
SOURCE: BioLargo, Inc.
View source version on accesswire.com:
https://www.accesswire.com/659042/BioLargo-Q2-2021-Earnings-Results-Webcast-and-Conference-Call-Wednesday-August-17-2021--1100-AM-Eastern-Time
